BREVILLE GROUP LIMITED DISCLOSUREInsider Transactions (Form 3/4/5)

Change of Director's Interest Notice

Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity BREVILLE GROUP LIMITED ABN 90 086 933 431 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director James D Clayton Date of last notice 26 November 2025 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. N/A Date of change 3 September 2026 (exercise of rights) and 4 to 8 September 2026 (sale of shares) No. of securities held prior to change Direct: 272,714 performance rights 179,384 deferred share rights 200,000 LTPR rights Indirect: 200,000 ordinary shares held by Citicorp Nominees Pty Limited as nominee for the Clayton Family Trust 3,500 ordinary shares held by Citicorp Nominees Pty Limited as nominee for James and Clementene Clayton (joint account) For personal use only Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 Class Ordinary shares, performance rights and deferred share rights Number acquired 137,804 ordinary shares Number disposed 108,474 performance rights 29,330 deferred share rights 137,804 ordinary shares Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation $4,365,323.27 (sale of shares) No. of securities held after change Direct: 164,240 performance rights 150,054 deferred share rights 200,000 L